drugset / Trial / NCT00230958
Study of Viramidine to Ribavirin in Patients With Chronic Hepatitis C Who Are Treatment-Naive
RandomizedParallel-groupDouble-blindTreatment
Summary
This purpose of this study is to determine the safety and effectiveness of viramidine to ribavirin in chronic hepatitis C patients who have never before recieved treatment.
Timeline
- Start
- 2003-12
- Primary completion
- 2006-01
- Completion
- 2006-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ribavirin | Small molecule | 1000 mg | — |
| Subject | Ribavirin | Small molecule | 1200 mg | — |
| Subject | Taribavirin | Small molecule | 600 mg | — |
| Background | Peginterferon alfa-2b | Protein / enzyme biologic | — | — |